Adenovirus type 4 a

Ended Awarded

Contract number
SPE2DP21F2621
Awardee
Awarding agency
Obligated
$705,884

Award facts

Opportunity
Contract value 100% obligated
$705,884.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Teva Pharmaceuticals USA, Inc. was awarded a $705,884.40 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The place of performance is Teva's facility located in Parsippany, New Jersey. The delivery order has a period of performance starting on March 10, 2021 through March 23, 2021. No major subcontractors or set aside designations were identified. DLA supports the Department of Defense by procuring pharmaceuticals and medical supplies, so this delivery order is likely associated with stocking critical medical countermeasures and protecting military readiness.

Quick answers

Who was awarded contract SPE2DP21F2621?

SPE2DP21F2621 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on March 10, 2021.

How much is contract SPE2DP21F2621 worth?

The government has obligated $705,884 on SPE2DP21F2621.

Is contract SPE2DP21F2621 an order under another contract?

Yes. SPE2DP21F2621 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP21F2621 competed?

The extent of competition for SPE2DP21F2621 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login